CYP2C19 Genetic Testing After PCI: A Promising Tool That Still Raises Practical Questions
CYP2C19 genotyping may personalize antiplatelet therapy after PCI, identifying patients at risk for reduced clopidogrel response while supporting more targeted treatment decisions.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.